Brief: Evolent Health Q4 Revenue USD 646.542 Million Vs. IBES Estimate USD 651.2 Million
20/02/2025 21:10
Feb 20 (Reuters) - Evolent Health Q4 adjusted EBITDA USD 22.612 million vs. IBES estimate USD 23.9 million. * Q4 adjusted EBITDA margin 3.5% * Q4 net income USD -30.615 million vs. IBES estimate USD 1.05 million * outlook FY adjusted EBITDA USD 135-165 million * outlook Q1 adjusted EBITDA USD 31-37 million
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows